drugset / Trial / NCT03706456

Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease

NCT03706456 ↗

Phase 3 Completed 22 enrolled Takeda
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of darvadstrocel for the treatment of complex perianal fistulas in adult participants with Crohn's disease over 24 weeks.

Timeline

Start
2019-03-06
Primary completion
2020-07-20
Completion
2023-02-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Darvadstrocel Cell therapy 24 ml Intramuscular
Subject Darvadstrocel Cell therapy 1.2e+08 cells Intramuscular